Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TLT.v -- Ignore unavailable to you. Want to Upgrade?

To: 3bar who wrote (1385)	9/30/2019 5:36:47 PM
From: ogi	2 Recommendations Recommended By 3bar WalterWhite Read Replies (1) \| Respond to of 1869

2 patients' survival rates are not what we want to hear, despite the fact it is great news. We need TLT to define its current progress and it failed at that today. Where are the U.S. trial sites, do they really only have 1 patient enrolled 5 farking months after the trial started? Really? They have been talking 20 sites in the U.S. and we don't have a single one yet. I certainly hope the first is MD Anderson cancer centre. How about TLT management statements of running a phase 1 trial on brain cancer while still underway on bladder cancer. TLT still needs to get work done and spark the market's interest in the near future. Of course this is the company that released a slew of great news and then did a PP instead of the normal approach which is to do a PP and then reward the buyers and the market with a slew of great news that raises the price of the stock. Ass backwards approach, ass backward share price!! I am pretty sure , based on past behaviour, there are more news release in the pipe. Today would have been better if it were paired with Phase 2 updates.